Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis
Wu Ting, Zuo Zhihong, Kang Shuntong, Jiang Liping, Luo Xuan, Xia Zanxian, Liu Jing, Xiao Xiaojuan, Ye Mao, Deng Meichun
Table 1 Clinical features of COVID-19 cases.
OverallOverall
CFR, % (95%CI)2(1-3)Laboratory results (95%CI)
CSR, % (95%CI)24(20-28)Liver function
Comorbidity, % (95%CI)ALT, U/L27.02(24.67-29.37)
Hypertension19(15-23)AST, U/L30.50(28.09-32.91)
Diabetes10(8-13)Total bilirubin, mmol/L11.10(10.16-12.04)
CVD8(4-14)Renal function
COPD2(2-3)Creatinine, μmol/L69.18(65.22-73.13)
Cerebrovascular diseases3(2-5)Urea mmol/L4.76(4.31-5.22)
CLD3(2-4)Cardiac function
CKD3(1-4)Myoglobin, ng/mL49.96(37.11-62.81)
Tumor3(1-5)CK, U/L84.69(74.51-94.86)
GI disease7(5-8)LDH, U/L275.43(247.82-303.04)
Nervous system disease1(0-2)hs-cTnI, pg/mL13.08(8.22-17.94)
Neurologic symptoms, % (95%CI)CT % (95%CI)
Headache15(9-23)Bilateral involvement of chest radiographs85(78-90)
Dizziness10(7-13)Complications% (95%CI)
Impaired consciousness9(8-10)ARDS12(7-18)
Olfactory and/or taste disorders.54(37-70)ACI6(3-9)
Olfactory disorders28(9-52)Shock6(2-11)
Taste disorders30(12-52)AKI4(1-7)
GI symptoms, % (95%CI)Acute cerebrovascular disease2(1-3)
Anorexia21(14-29)GI symptoms, % (95%CI)
Abdominal pain5(2-10)Nausea7(4-11)
Diarrhea9(6-12)Vomiting5(1-10)